H12_HUMAN - dbPTM
H12_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H12_HUMAN
UniProt AC P16403
Protein Name Histone H1.2
Gene Name HIST1H1C
Organism Homo sapiens (Human).
Sequence Length 213
Subcellular Localization Nucleus. Chromosome. Mainly localizes in euchromatin. Distribution goes in parallel with DNA concentration.
Protein Description Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity)..
Protein Sequence MSETAPAAPAAAPPAEKAPVKKKAAKKAGGTPRKASGPPVSELITKAVAASKERSGVSLAALKKALAAAGYDVEKNNSRIKLGLKSLVSKGTLVQTKGTGASGSFKLNKKAASGEAKPKVKKAGGTKPKKPVGAAKKPKKAAGGATPKKSAKKTPKKAKKPAAATVTKKVAKSPKKAKVAKPKKAAKSAAKAVKPKAAKPKVVKPKKAAPKKK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSETAPAAP
------CCCCCCCCC
43.5919691289
2Phosphorylation------MSETAPAAP
------CCCCCCCCC
43.5929255136
4Phosphorylation----MSETAPAAPAA
----CCCCCCCCCCC
30.5429255136
17AcetylationAAAPPAEKAPVKKKA
CCCCCHHHCCCCHHH
61.1623749302
17UbiquitinationAAAPPAEKAPVKKKA
CCCCCHHHCCCCHHH
61.1623000965
21GlycationPAEKAPVKKKAAKKA
CHHHCCCCHHHHHHC
47.71-
21UbiquitinationPAEKAPVKKKAAKKA
CHHHCCCCHHHHHHC
47.7123000965
22GlycationAEKAPVKKKAAKKAG
HHHCCCCHHHHHHCC
48.13-
22UbiquitinationAEKAPVKKKAAKKAG
HHHCCCCHHHHHHCC
48.1323000965
23GlycationEKAPVKKKAAKKAGG
HHCCCCHHHHHHCCC
48.11-
23OtherEKAPVKKKAAKKAGG
HHCCCCHHHHHHCCC
48.1124681537
23UbiquitinationEKAPVKKKAAKKAGG
HHCCCCHHHHHHCCC
48.1123000965
26AcetylationPVKKKAAKKAGGTPR
CCCHHHHHHCCCCCC
48.27-
26MethylationPVKKKAAKKAGGTPR
CCCHHHHHHCCCCCC
48.2717043054
26OtherPVKKKAAKKAGGTPR
CCCHHHHHHCCCCCC
48.2724681537
27GlycationVKKKAAKKAGGTPRK
CCHHHHHHCCCCCCC
47.76-
27LactylationVKKKAAKKAGGTPRK
CCHHHHHHCCCCCCC
47.7631645732
27OtherVKKKAAKKAGGTPRK
CCHHHHHHCCCCCCC
47.7624681537
31PhosphorylationAAKKAGGTPRKASGP
HHHHCCCCCCCCCCC
20.9926329039
34N6-crotonyl-L-lysineKAGGTPRKASGPPVS
HCCCCCCCCCCCCHH
48.37-
34AcetylationKAGGTPRKASGPPVS
HCCCCCCCCCCCCHH
48.3717043054
34CrotonylationKAGGTPRKASGPPVS
HCCCCCCCCCCCCHH
48.3721925322
34MalonylationKAGGTPRKASGPPVS
HCCCCCCCCCCCCHH
48.3726320211
34MethylationKAGGTPRKASGPPVS
HCCCCCCCCCCCCHH
48.3717043054
34OtherKAGGTPRKASGPPVS
HCCCCCCCCCCCCHH
48.37-
34UbiquitinationKAGGTPRKASGPPVS
HCCCCCCCCCCCCHH
48.3723000965
36PhosphorylationGGTPRKASGPPVSEL
CCCCCCCCCCCHHHH
55.6729255136
41PhosphorylationKASGPPVSELITKAV
CCCCCCHHHHHHHHH
32.2430266825
45PhosphorylationPPVSELITKAVAASK
CCHHHHHHHHHHHHH
26.1030266825
46UbiquitinationPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.5921890473
46AcetylationPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.5922641341
46MalonylationPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.5926320211
46MethylationPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.5917043054
46OtherPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.5924681537
46UbiquitinationPVSELITKAVAASKE
CHHHHHHHHHHHHHH
33.5925015289
51PhosphorylationITKAVAASKERSGVS
HHHHHHHHHHCCCCC
25.8826546556
52AcetylationTKAVAASKERSGVSL
HHHHHHHHHCCCCCH
53.047296767
52LactylationTKAVAASKERSGVSL
HHHHHHHHHCCCCCH
53.0431645732
52MethylationTKAVAASKERSGVSL
HHHHHHHHHCCCCCH
53.0417043054
52OtherTKAVAASKERSGVSL
HHHHHHHHHCCCCCH
53.0424681537
52UbiquitinationTKAVAASKERSGVSL
HHHHHHHHHCCCCCH
53.0423000965
54CitrullinationAVAASKERSGVSLAA
HHHHHHHCCCCCHHH
42.31-
54CitrullinationAVAASKERSGVSLAA
HHHHHHHCCCCCHHH
42.31-
54MethylationAVAASKERSGVSLAA
HHHHHHHCCCCCHHH
42.31-
55PhosphorylationVAASKERSGVSLAAL
HHHHHHCCCCCHHHH
44.6430266825
58PhosphorylationSKERSGVSLAALKKA
HHHCCCCCHHHHHHH
18.8030266825
63AcetylationGVSLAALKKALAAAG
CCCHHHHHHHHHHCC
31.13163891
63MalonylationGVSLAALKKALAAAG
CCCHHHHHHHHHHCC
31.1326320211
63MethylationGVSLAALKKALAAAG
CCCHHHHHHHHHHCC
31.1317043054
63OtherGVSLAALKKALAAAG
CCCHHHHHHHHHHCC
31.1324681537
63UbiquitinationGVSLAALKKALAAAG
CCCHHHHHHHHHHCC
31.1323000965
64UbiquitinationVSLAALKKALAAAGY
CCHHHHHHHHHHCCC
49.8621890473
64N6-crotonyl-L-lysineVSLAALKKALAAAGY
CCHHHHHHHHHHCCC
49.86-
64AcetylationVSLAALKKALAAAGY
CCHHHHHHHHHHCCC
49.8617043054
64CrotonylationVSLAALKKALAAAGY
CCHHHHHHHHHHCCC
49.8621925322
64MalonylationVSLAALKKALAAAGY
CCHHHHHHHHHHCCC
49.8626320211
64OtherVSLAALKKALAAAGY
CCHHHHHHHHHHCCC
49.8624681537
64SumoylationVSLAALKKALAAAGY
CCHHHHHHHHHHCCC
49.8617043054
64UbiquitinationVSLAALKKALAAAGY
CCHHHHHHHHHHCCC
49.8623000965
71PhosphorylationKALAAAGYDVEKNNS
HHHHHCCCCCHHCCC
16.4628152594
75UbiquitinationAAGYDVEKNNSRIKL
HCCCCCHHCCCCCCC
62.3721890473
75AcetylationAAGYDVEKNNSRIKL
HCCCCCHHCCCCCCC
62.37158559
75MalonylationAAGYDVEKNNSRIKL
HCCCCCHHCCCCCCC
62.3726320211
75MethylationAAGYDVEKNNSRIKL
HCCCCCHHCCCCCCC
62.37-
75OtherAAGYDVEKNNSRIKL
HCCCCCHHCCCCCCC
62.3724681537
75UbiquitinationAAGYDVEKNNSRIKL
HCCCCCHHCCCCCCC
62.3723000965
78PhosphorylationYDVEKNNSRIKLGLK
CCCHHCCCCCCCCHH
44.7923401153
81OtherEKNNSRIKLGLKSLV
HHCCCCCCCCHHHHH
35.0824681537
81UbiquitinationEKNNSRIKLGLKSLV
HHCCCCCCCCHHHHH
35.0823000965
85UbiquitinationSRIKLGLKSLVSKGT
CCCCCCHHHHHHCCC
39.6921890473
85N6-crotonyl-L-lysineSRIKLGLKSLVSKGT
CCCCCCHHHHHHCCC
39.69-
85AcetylationSRIKLGLKSLVSKGT
CCCCCCHHHHHHCCC
39.6972630437
85CrotonylationSRIKLGLKSLVSKGT
CCCCCCHHHHHHCCC
39.6921925322
85MalonylationSRIKLGLKSLVSKGT
CCCCCCHHHHHHCCC
39.6926320211
85OtherSRIKLGLKSLVSKGT
CCCCCCHHHHHHCCC
39.6924681537
85UbiquitinationSRIKLGLKSLVSKGT
CCCCCCHHHHHHCCC
39.6923000965
86PhosphorylationRIKLGLKSLVSKGTL
CCCCCHHHHHHCCCE
38.7620860994
89PhosphorylationLGLKSLVSKGTLVQT
CCHHHHHHCCCEEEE
30.5717877366
90UbiquitinationGLKSLVSKGTLVQTK
CHHHHHHCCCEEEEC
48.7321890473
90N6-crotonyl-L-lysineGLKSLVSKGTLVQTK
CHHHHHHCCCEEEEC
48.73-
90AcetylationGLKSLVSKGTLVQTK
CHHHHHHCCCEEEEC
48.7317043054
90CrotonylationGLKSLVSKGTLVQTK
CHHHHHHCCCEEEEC
48.7321925322
90LactylationGLKSLVSKGTLVQTK
CHHHHHHCCCEEEEC
48.7331645732
90MalonylationGLKSLVSKGTLVQTK
CHHHHHHCCCEEEEC
48.7326320211
90OtherGLKSLVSKGTLVQTK
CHHHHHHCCCEEEEC
48.7324681537
90UbiquitinationGLKSLVSKGTLVQTK
CHHHHHHCCCEEEEC
48.7323000965
92PhosphorylationKSLVSKGTLVQTKGT
HHHHHCCCEEEECCC
27.7417877366
96PhosphorylationSKGTLVQTKGTGASG
HCCCEEEECCCCCCC
24.7828111955
97UbiquitinationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.0721890473
97N6-crotonyl-L-lysineKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.07-
97AcetylationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.0717043054
97CrotonylationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.0721925322
97LactylationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.0731645732
97MalonylationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.0726320211
97OtherKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.0724681537
97SuccinylationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.07-
97UbiquitinationKGTLVQTKGTGASGS
CCCEEEECCCCCCCC
37.0723000965
99PhosphorylationTLVQTKGTGASGSFK
CEEEECCCCCCCCEE
31.0026657352
102PhosphorylationQTKGTGASGSFKLNK
EECCCCCCCCEECCC
35.9925159151
104PhosphorylationKGTGASGSFKLNKKA
CCCCCCCCEECCCCC
19.4023401153
106UbiquitinationTGASGSFKLNKKAAS
CCCCCCEECCCCCCC
53.5021890473
106AcetylationTGASGSFKLNKKAAS
CCCCCCEECCCCCCC
53.5022641351
106MalonylationTGASGSFKLNKKAAS
CCCCCCEECCCCCCC
53.5026320211
106OtherTGASGSFKLNKKAAS
CCCCCCEECCCCCCC
53.50-
106UbiquitinationTGASGSFKLNKKAAS
CCCCCCEECCCCCCC
53.5021906983
109UbiquitinationSGSFKLNKKAASGEA
CCCEECCCCCCCCCC
54.9822817900
110OtherGSFKLNKKAASGEAK
CCEECCCCCCCCCCC
48.3824681537
110UbiquitinationGSFKLNKKAASGEAK
CCEECCCCCCCCCCC
48.3821906983
113PhosphorylationKLNKKAASGEAKPKV
ECCCCCCCCCCCCCC
41.8626657352
117AcetylationKAASGEAKPKVKKAG
CCCCCCCCCCCCCCC
40.8626051181
117OtherKAASGEAKPKVKKAG
CCCCCCCCCCCCCCC
40.8624681537
117UbiquitinationKAASGEAKPKVKKAG
CCCCCCCCCCCCCCC
40.8621906983
119MethylationASGEAKPKVKKAGGT
CCCCCCCCCCCCCCC
67.01-
119UbiquitinationASGEAKPKVKKAGGT
CCCCCCCCCCCCCCC
67.0122817900
121OtherGEAKPKVKKAGGTKP
CCCCCCCCCCCCCCC
42.9324681537
121UbiquitinationGEAKPKVKKAGGTKP
CCCCCCCCCCCCCCC
42.9322817900
122UbiquitinationEAKPKVKKAGGTKPK
CCCCCCCCCCCCCCC
56.0822817900
126PhosphorylationKVKKAGGTKPKKPVG
CCCCCCCCCCCCCCC
43.16-
127UbiquitinationVKKAGGTKPKKPVGA
CCCCCCCCCCCCCCC
59.1021906983
129OtherKAGGTKPKKPVGAAK
CCCCCCCCCCCCCCC
71.8624681537
129UbiquitinationKAGGTKPKKPVGAAK
CCCCCCCCCCCCCCC
71.8622817900
130UbiquitinationAGGTKPKKPVGAAKK
CCCCCCCCCCCCCCC
54.1622817900
136GlycationKKPVGAAKKPKKAAG
CCCCCCCCCCCCCCC
69.90-
136OtherKKPVGAAKKPKKAAG
CCCCCCCCCCCCCCC
69.9024681537
136UbiquitinationKKPVGAAKKPKKAAG
CCCCCCCCCCCCCCC
69.9022817900
137UbiquitinationKPVGAAKKPKKAAGG
CCCCCCCCCCCCCCC
58.2922817900
139UbiquitinationVGAAKKPKKAAGGAT
CCCCCCCCCCCCCCC
65.0222817900
140LactylationGAAKKPKKAAGGATP
CCCCCCCCCCCCCCC
52.5831645732
140UbiquitinationGAAKKPKKAAGGATP
CCCCCCCCCCCCCCC
52.5821906983
146PhosphorylationKKAAGGATPKKSAKK
CCCCCCCCCCCCCCC
38.6330266825
148OtherAAGGATPKKSAKKTP
CCCCCCCCCCCCCCC
55.8124681537
148UbiquitinationAAGGATPKKSAKKTP
CCCCCCCCCCCCCCC
55.8133845483
153UbiquitinationTPKKSAKKTPKKAKK
CCCCCCCCCCCCCCC
70.5423503661
154PhosphorylationPKKSAKKTPKKAKKP
CCCCCCCCCCCCCCC
39.37-
156UbiquitinationKSAKKTPKKAKKPAA
CCCCCCCCCCCCCCH
71.2722817900
157AcetylationSAKKTPKKAKKPAAA
CCCCCCCCCCCCCHH
67.647429635
157GlycationSAKKTPKKAKKPAAA
CCCCCCCCCCCCCHH
67.64-
157UbiquitinationSAKKTPKKAKKPAAA
CCCCCCCCCCCCCHH
67.6422817900
159N6-crotonyl-L-lysineKKTPKKAKKPAAATV
CCCCCCCCCCCHHHH
69.07-
159AcetylationKKTPKKAKKPAAATV
CCCCCCCCCCCHHHH
69.0726051181
159CrotonylationKKTPKKAKKPAAATV
CCCCCCCCCCCHHHH
69.0721925322
159OtherKKTPKKAKKPAAATV
CCCCCCCCCCCHHHH
69.0724681537
159UbiquitinationKKTPKKAKKPAAATV
CCCCCCCCCCCHHHH
69.0722817900
160AcetylationKTPKKAKKPAAATVT
CCCCCCCCCCHHHHH
44.767429651
160UbiquitinationKTPKKAKKPAAATVT
CCCCCCCCCCHHHHH
44.7621906983
165PhosphorylationAKKPAAATVTKKVAK
CCCCCHHHHHHHHHC
24.7930266825
167PhosphorylationKPAAATVTKKVAKSP
CCCHHHHHHHHHCCC
22.3130266825
168N6-crotonyl-L-lysinePAAATVTKKVAKSPK
CCHHHHHHHHHCCCC
40.70-
168AcetylationPAAATVTKKVAKSPK
CCHHHHHHHHHCCCC
40.7017043054
168CrotonylationPAAATVTKKVAKSPK
CCHHHHHHHHHCCCC
40.7021925322
168LactylationPAAATVTKKVAKSPK
CCHHHHHHHHHCCCC
40.7031645732
168MethylationPAAATVTKKVAKSPK
CCHHHHHHHHHCCCC
40.70-
168OtherPAAATVTKKVAKSPK
CCHHHHHHHHHCCCC
40.7024681537
168UbiquitinationPAAATVTKKVAKSPK
CCHHHHHHHHHCCCC
40.7027667366
169AcetylationAAATVTKKVAKSPKK
CHHHHHHHHHCCCCC
37.75164213
169UbiquitinationAAATVTKKVAKSPKK
CHHHHHHHHHCCCCC
37.7522817900
172GlycationTVTKKVAKSPKKAKV
HHHHHHHCCCCCCCC
70.99-
172UbiquitinationTVTKKVAKSPKKAKV
HHHHHHHCCCCCCCC
70.9922817900
173PhosphorylationVTKKVAKSPKKAKVA
HHHHHHCCCCCCCCC
32.0130278072
175GlycationKKVAKSPKKAKVAKP
HHHHCCCCCCCCCCH
72.89-
178UbiquitinationAKSPKKAKVAKPKKA
HCCCCCCCCCCHHHH
52.16-
187"N6,N6-dimethyllysine"AKPKKAAKSAAKAVK
CCHHHHHHHHHHHHC
45.55-
187AcetylationAKPKKAAKSAAKAVK
CCHHHHHHHHHHHHC
45.557704193
187MethylationAKPKKAAKSAAKAVK
CCHHHHHHHHHHHHC
45.5520334638
188ADP-ribosylationKPKKAAKSAAKAVKP
CHHHHHHHHHHHHCC
28.8227723750
188PhosphorylationKPKKAAKSAAKAVKP
CHHHHHHHHHHHHCC
28.82-
191AcetylationKAAKSAAKAVKPKAA
HHHHHHHHHHCCCCC
54.1217043054
191LactylationKAAKSAAKAVKPKAA
HHHHHHHHHHCCCCC
54.1231645732
191UbiquitinationKAAKSAAKAVKPKAA
HHHHHHHHHHCCCCC
54.1233845483
194UbiquitinationKSAAKAVKPKAAKPK
HHHHHHHCCCCCCCC
45.7325015289
196UbiquitinationAAKAVKPKAAKPKVV
HHHHHCCCCCCCCCC
56.0825015289
199GlycationAVKPKAAKPKVVKPK
HHCCCCCCCCCCCCC
50.67-
199UbiquitinationAVKPKAAKPKVVKPK
HHCCCCCCCCCCCCC
50.6725015289
201GlycationKPKAAKPKVVKPKKA
CCCCCCCCCCCCCCC
59.98-
201LactylationKPKAAKPKVVKPKKA
CCCCCCCCCCCCCCC
59.9831645732
201UbiquitinationKPKAAKPKVVKPKKA
CCCCCCCCCCCCCCC
59.9822817900
204UbiquitinationAAKPKVVKPKKAAPK
CCCCCCCCCCCCCCC
54.8522817900
206UbiquitinationKPKVVKPKKAAPKKK
CCCCCCCCCCCCCCC
49.6922817900
207UbiquitinationPKVVKPKKAAPKKK-
CCCCCCCCCCCCCC-
59.3022817900
211UbiquitinationKPKKAAPKKK-----
CCCCCCCCCC-----
69.3522817900
213OtherKKAAPKKK-------
CCCCCCCC-------
72.2424681537

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
36SPhosphorylationKinaseCHEK2O96017
GPS
55SPhosphorylationKinaseCHEK2O96017
GPS
89SPhosphorylationKinaseCHEK2O96017
GPS
92TPhosphorylationKinaseCHEK2O96017
GPS
104SPhosphorylationKinasePKC-Uniprot
146TPhosphorylationKinasePRKDCP78527
GPS
167TPhosphorylationKinaseCHEK2O96017
GPS
-KUbiquitinationE3 ubiquitin ligaseITCHQ96J02
PMID:30517763

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
54RCitrullination

-

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of H12_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SUZ12_HUMANSUZ12physical
16431907
EED_HUMANEEDphysical
16431907
AEBP2_HUMANAEBP2physical
16431907
PRKDC_HUMANPRKDCphysical
18258596
ASXL1_HUMANASXL1physical
18258596
PARP1_HUMANPARP1physical
18258596
IMA8_HUMANKPNA7physical
18258596
NUCL_HUMANNCLphysical
18258596
CTNB1_HUMANCTNNB1physical
18258596
IMB1_HUMANKPNB1physical
18258596
WDR5_HUMANWDR5physical
18258596
WDR12_HUMANWDR12physical
18258596
RBM39_HUMANRBM39physical
18258596
YBOX1_HUMANYBX1physical
18258596
PUF60_HUMANPUF60physical
18258596
H1X_HUMANH1FXphysical
22939629
H2A1D_HUMANHIST1H2ADphysical
22939629
IL7RA_HUMANIL7Rphysical
23151878
SC24D_HUMANSEC24Dphysical
22863883
CUL4A_HUMANCUL4Aphysical
24360965
PAF1_HUMANPAF1physical
24360965
LEO1_HUMANLEO1physical
24360965
RPB1_HUMANPOLR2Aphysical
24360965
CTR9_HUMANCTR9physical
24360965
CDC73_HUMANCDC73physical
24360965
WDR61_HUMANWDR61physical
24360965
DDB1_HUMANDDB1physical
24360965
RBX1_HUMANRBX1physical
24360965
WDR5_HUMANWDR5physical
24360965
DCAF1_HUMANVPRBPphysical
24360965
FIP1_HUMANFIP1L1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H12_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry.";
Meierhofer D., Wang X., Huang L., Kaiser P.;
J. Proteome Res. 7:4566-4576(2008).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, UBIQUITINATION [LARGESCALE ANALYSIS] AT LYS-17, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND THR-4, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, AND MASSSPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-36 AND THR-146,AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-31 AND SER-36, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-31 AND SER-173, AND MASSSPECTROMETRY.
Ubiquitylation
ReferencePubMed
"Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry.";
Meierhofer D., Wang X., Huang L., Kaiser P.;
J. Proteome Res. 7:4566-4576(2008).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, UBIQUITINATION [LARGESCALE ANALYSIS] AT LYS-17, AND MASS SPECTROMETRY.
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry.";
Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
Proteomics 7:868-874(2007).
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-206, AND MASSSPECTROMETRY.

TOP